WASHINGTON — Results from a U.S. trial of AstraZeneca’s COVID-19 vaccine may have used “outdated information,” U.S. federal health officials said early Tuesday. The Data and Safety Monitoring Board said in a statement that it was concerned that AstraZeneca may have provided an incomplete view of the efficacy data. AstraZeneca reported Monday that its COVID-19 vaccine…
Source: NY Post click here for more…